Abstract
Summary
The global Epigenome Analysis Services market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Epigenome Analysis Services Industry Forecast” looks at past sales and reviews total world Epigenome Analysis Services sales in 2023, providing a comprehensive analysis by region and market sector of projected Epigenome Analysis Services sales for 2024 through 2030. With Epigenome Analysis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epigenome Analysis Services industry.
This Insight Report provides a comprehensive analysis of the global Epigenome Analysis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Epigenome Analysis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epigenome Analysis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epigenome Analysis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epigenome Analysis Services.
United States market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Epigenome Analysis Services players cover Cellcentric, Syndax, Illumina, Merck and QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenome Analysis Services market by product type, application, key players and key regions and countries.
Segmentation by type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segmentation by application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
LPI (LP Information)' newest research report, the “Epigenome Analysis Services Industry Forecast” looks at past sales and reviews total world Epigenome Analysis Services sales in 2023, providing a comprehensive analysis by region and market sector of projected Epigenome Analysis Services sales for 2024 through 2030. With Epigenome Analysis Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Epigenome Analysis Services industry.
This Insight Report provides a comprehensive analysis of the global Epigenome Analysis Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Epigenome Analysis Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Epigenome Analysis Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Epigenome Analysis Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Epigenome Analysis Services.
United States market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Epigenome Analysis Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Epigenome Analysis Services players cover Cellcentric, Syndax, Illumina, Merck and QIAGEN, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Epigenome Analysis Services market by product type, application, key players and key regions and countries.
Segmentation by type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segmentation by application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Epigenome Analysis Services Market Size 2019-2030
2.1.2 Epigenome Analysis Services Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Epigenome Analysis Services Segment by Type
2.2.1 DNA Methylation Analysis
2.2.2 Analysis of DNA Interactions
2.2.3 Chromatin Accessibility
2.2.4 Conformation Assays
2.3 Epigenome Analysis Services Market Size by Type
2.3.1 Epigenome Analysis Services Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Epigenome Analysis Services Market Size Market Share by Type (2019-2024)
2.4 Epigenome Analysis Services Segment by Application
2.4.1 Research Institutes
2.4.2 Pharmaceutical Companies
2.4.3 Biotechnology Companies
2.4.4 Others
2.5 Epigenome Analysis Services Market Size by Application
2.5.1 Epigenome Analysis Services Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Epigenome Analysis Services Market Size Market Share by Application (2019-2024)
3 Epigenome Analysis Services Market Size by Player
3.1 Epigenome Analysis Services Market Size Market Share by Players
3.1.1 Global Epigenome Analysis Services Revenue by Players (2019-2024)
3.1.2 Global Epigenome Analysis Services Revenue Market Share by Players (2019-2024)
3.2 Global Epigenome Analysis Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Epigenome Analysis Services by Regions
4.1 Epigenome Analysis Services Market Size by Regions (2019-2024)
4.2 Americas Epigenome Analysis Services Market Size Growth (2019-2024)
4.3 APAC Epigenome Analysis Services Market Size Growth (2019-2024)
4.4 Europe Epigenome Analysis Services Market Size Growth (2019-2024)
4.5 Middle East & Africa Epigenome Analysis Services Market Size Growth (2019-2024)
5 Americas
5.1 Americas Epigenome Analysis Services Market Size by Country (2019-2024)
5.2 Americas Epigenome Analysis Services Market Size by Type (2019-2024)
5.3 Americas Epigenome Analysis Services Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Epigenome Analysis Services Market Size by Region (2019-2024)
6.2 APAC Epigenome Analysis Services Market Size by Type (2019-2024)
6.3 APAC Epigenome Analysis Services Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Epigenome Analysis Services by Country (2019-2024)
7.2 Europe Epigenome Analysis Services Market Size by Type (2019-2024)
7.3 Europe Epigenome Analysis Services Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Epigenome Analysis Services by Region (2019-2024)
8.2 Middle East & Africa Epigenome Analysis Services Market Size by Type (2019-2024)
8.3 Middle East & Africa Epigenome Analysis Services Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Epigenome Analysis Services Market Forecast
10.1 Global Epigenome Analysis Services Forecast by Regions (2025-2030)
10.1.1 Global Epigenome Analysis Services Forecast by Regions (2025-2030)
10.1.2 Americas Epigenome Analysis Services Forecast
10.1.3 APAC Epigenome Analysis Services Forecast
10.1.4 Europe Epigenome Analysis Services Forecast
10.1.5 Middle East & Africa Epigenome Analysis Services Forecast
10.2 Americas Epigenome Analysis Services Forecast by Country (2025-2030)
10.2.1 United States Epigenome Analysis Services Market Forecast
10.2.2 Canada Epigenome Analysis Services Market Forecast
10.2.3 Mexico Epigenome Analysis Services Market Forecast
10.2.4 Brazil Epigenome Analysis Services Market Forecast
10.3 APAC Epigenome Analysis Services Forecast by Region (2025-2030)
10.3.1 China Epigenome Analysis Services Market Forecast
10.3.2 Japan Epigenome Analysis Services Market Forecast
10.3.3 Korea Epigenome Analysis Services Market Forecast
10.3.4 Southeast Asia Epigenome Analysis Services Market Forecast
10.3.5 India Epigenome Analysis Services Market Forecast
10.3.6 Australia Epigenome Analysis Services Market Forecast
10.4 Europe Epigenome Analysis Services Forecast by Country (2025-2030)
10.4.1 Germany Epigenome Analysis Services Market Forecast
10.4.2 France Epigenome Analysis Services Market Forecast
10.4.3 UK Epigenome Analysis Services Market Forecast
10.4.4 Italy Epigenome Analysis Services Market Forecast
10.4.5 Russia Epigenome Analysis Services Market Forecast
10.5 Middle East & Africa Epigenome Analysis Services Forecast by Region (2025-2030)
10.5.1 Egypt Epigenome Analysis Services Market Forecast
10.5.2 South Africa Epigenome Analysis Services Market Forecast
10.5.3 Israel Epigenome Analysis Services Market Forecast
10.5.4 Turkey Epigenome Analysis Services Market Forecast
10.5.5 GCC Countries Epigenome Analysis Services Market Forecast
10.6 Global Epigenome Analysis Services Forecast by Type (2025-2030)
10.7 Global Epigenome Analysis Services Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Cellcentric
11.1.1 Cellcentric Company Information
11.1.2 Cellcentric Epigenome Analysis Services Product Offered
11.1.3 Cellcentric Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Cellcentric Main Business Overview
11.1.5 Cellcentric Latest Developments
11.2 Syndax
11.2.1 Syndax Company Information
11.2.2 Syndax Epigenome Analysis Services Product Offered
11.2.3 Syndax Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Syndax Main Business Overview
11.2.5 Syndax Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Epigenome Analysis Services Product Offered
11.3.3 Illumina Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Epigenome Analysis Services Product Offered
11.4.3 Merck Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Epigenome Analysis Services Product Offered
11.5.3 QIAGEN Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Information
11.6.2 F. Hoffmann-La Roche Epigenome Analysis Services Product Offered
11.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 F. Hoffmann-La Roche Main Business Overview
11.6.5 F. Hoffmann-La Roche Latest Developments
11.7 Eisai
11.7.1 Eisai Company Information
11.7.2 Eisai Epigenome Analysis Services Product Offered
11.7.3 Eisai Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Eisai Main Business Overview
11.7.5 Eisai Latest Developments
11.8 Abcam
11.8.1 Abcam Company Information
11.8.2 Abcam Epigenome Analysis Services Product Offered
11.8.3 Abcam Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Abcam Main Business Overview
11.8.5 Abcam Latest Developments
11.9 Diagenode
11.9.1 Diagenode Company Information
11.9.2 Diagenode Epigenome Analysis Services Product Offered
11.9.3 Diagenode Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Diagenode Main Business Overview
11.9.5 Diagenode Latest Developments
11.10 Active Motif
11.10.1 Active Motif Company Information
11.10.2 Active Motif Epigenome Analysis Services Product Offered
11.10.3 Active Motif Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Active Motif Main Business Overview
11.10.5 Active Motif Latest Developments
11.11 Zymo Research Corporation
11.11.1 Zymo Research Corporation Company Information
11.11.2 Zymo Research Corporation Epigenome Analysis Services Product Offered
11.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Zymo Research Corporation Main Business Overview
11.11.5 Zymo Research Corporation Latest Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Information
11.12.2 Thermo Fisher Scientific Epigenome Analysis Services Product Offered
11.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Thermo Fisher Scientific Main Business Overview
11.12.5 Thermo Fisher Scientific Latest Developments
11.13 Enzo Life Sciences
11.13.1 Enzo Life Sciences Company Information
11.13.2 Enzo Life Sciences Epigenome Analysis Services Product Offered
11.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Enzo Life Sciences Main Business Overview
11.13.5 Enzo Life Sciences Latest Developments
11.14 EpiGentek Group
11.14.1 EpiGentek Group Company Information
11.14.2 EpiGentek Group Epigenome Analysis Services Product Offered
11.14.3 EpiGentek Group Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EpiGentek Group Main Business Overview
11.14.5 EpiGentek Group Latest Developments
11.15 New England Biolabs
11.15.1 New England Biolabs Company Information
11.15.2 New England Biolabs Epigenome Analysis Services Product Offered
11.15.3 New England Biolabs Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 New England Biolabs Main Business Overview
11.15.5 New England Biolabs Latest Developments
11.16 Epizyme
11.16.1 Epizyme Company Information
11.16.2 Epizyme Epigenome Analysis Services Product Offered
11.16.3 Epizyme Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Epizyme Main Business Overview
11.16.5 Epizyme Latest Developments
11.17 Domainex
11.17.1 Domainex Company Information
11.17.2 Domainex Epigenome Analysis Services Product Offered
11.17.3 Domainex Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Domainex Main Business Overview
11.17.5 Domainex Latest Developments
11.18 Agilent Technologies
11.18.1 Agilent Technologies Company Information
11.18.2 Agilent Technologies Epigenome Analysis Services Product Offered
11.18.3 Agilent Technologies Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Agilent Technologies Main Business Overview
11.18.5 Agilent Technologies Latest Developments
11.19 AsisChem
11.19.1 AsisChem Company Information
11.19.2 AsisChem Epigenome Analysis Services Product Offered
11.19.3 AsisChem Epigenome Analysis Services Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 AsisChem Main Business Overview
11.19.5 AsisChem Latest Developments
12 Research Findings and Conclusion